Skip to main content
Erschienen in:

22.10.2016 | Original Paper

Histopathology of valves in infective endocarditis, diagnostic criteria and treatment considerations

verfasst von: Tatiana J. D. Brandão, Carolina A. Januario-da-Silva, Marcelo G. Correia, Monica Zappa, Jaime A. Abrantes, Angela M. R. Dantas, Wilma Golebiovski, Giovanna Ianini F. Barbosa, Clara Weksler, Cristiane C. Lamas

Erschienen in: Infection | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Infective endocarditis (IE) is a severe disease. Pathogen isolation is fundamental so as to treat effectively and reduce morbidity and mortality. Blood and valve culture and histopathology (HP) are routinely employed for this purpose. Valve HP is the gold standard for diagnosis.

Objectives

To determine the sensitivity and specificity of clinical criteria for IE (the modified Duke and the St Thomas’ minor modifications, STH) of blood and valve culture compared to valve HP, and to evaluate antibiotic treatment duration.

Methods

Prospective case series of patients, from 2006 to 2014 with surgically treated IE. Statistical analysis was done by the R software.

Results

There were 136 clinically definite episodes of IE in 133 patients. Mean age ± SD was 43 ± 15.6 years and IE was left sided in 81.6 %. HP was definite in 96 valves examined, which were used as gold standard. Sensitivity of blood culture was 61 % (CI 0.51, 0.71) and of valve culture 15 % (CI 0.07, 0.26). The modified Duke criteria were 65 % (CI 0.55, 0.75) sensitive and 33 % specific, while the STH’s sensitivity was 72 % (CI 0.61, 0.80) with similar specificity. In multivariate analysis and logistic regression, the only variable with statistical significance was duration of antibiotic therapy postoperatively.

Conclusions

Valve HP had high sensitivity and valve culture low sensitivity in the diagnosis of IE. The STH’s criteria were more sensitive than the modified Duke criteria. Valve HP should guide duration of postoperative antibiotic treatment.
Literatur
1.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis. The task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:3075–128.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis. The task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:3075–128.CrossRefPubMed
2.
Zurück zum Zitat Baddour LM, Wilson W, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association. Endorsed by the Infectious Diseases Society of America. Circulation. 2015;132:1435–86.CrossRefPubMed Baddour LM, Wilson W, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association. Endorsed by the Infectious Diseases Society of America. Circulation. 2015;132:1435–86.CrossRefPubMed
3.
Zurück zum Zitat Murdoch DR, Corey RG, Hoen B, et al. Clinical Presentation, Etiology and Outcome of Infective Endocarditis in the 21st Century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral Murdoch DR, Corey RG, Hoen B, et al. Clinical Presentation, Etiology and Outcome of Infective Endocarditis in the 21st Century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.CrossRefPubMed Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.CrossRefPubMed
5.
Zurück zum Zitat Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.CrossRefPubMed Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.CrossRefPubMed
6.
Zurück zum Zitat Tattevin P, Watt G, Revest M, et al. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45:1–8.CrossRefPubMed Tattevin P, Watt G, Revest M, et al. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45:1–8.CrossRefPubMed
7.
Zurück zum Zitat Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.CrossRefPubMed Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:131–40.CrossRefPubMed
8.
Zurück zum Zitat De Paula DHG, Tura BR, Lamas CC. Adverse events related to intravenous antibiotic therapy: a prospective observational study in the treatment of infective endocarditis. BMJ Open. 2012;2:e001189.CrossRefPubMedPubMedCentral De Paula DHG, Tura BR, Lamas CC. Adverse events related to intravenous antibiotic therapy: a prospective observational study in the treatment of infective endocarditis. BMJ Open. 2012;2:e001189.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Greub G, Lepidi H, Rovery C, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med. 2005;118:230–8.CrossRefPubMed Greub G, Lepidi H, Rovery C, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med. 2005;118:230–8.CrossRefPubMed
11.
Zurück zum Zitat Lepidi H, Durack DT, Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin N Am. 2002;16:336–9.CrossRef Lepidi H, Durack DT, Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin N Am. 2002;16:336–9.CrossRef
13.
Zurück zum Zitat Lamas CC. Diagnostic strategy for blood culture—negative endocarditis. Clin Infect Dis. 2010;51:141–2.CrossRefPubMed Lamas CC. Diagnostic strategy for blood culture—negative endocarditis. Clin Infect Dis. 2010;51:141–2.CrossRefPubMed
14.
Zurück zum Zitat Lamas CC, Fournier PE, Zappa M, et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection. 2015;. doi:10.1007/s15010-015-0863-x. Lamas CC, Fournier PE, Zappa M, et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection. 2015;. doi:10.​1007/​s15010-015-0863-x.
15.
Zurück zum Zitat Harris KA, Yam T, Jalili S, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis. 2014;33:2061–6.CrossRefPubMedPubMedCentral Harris KA, Yam T, Jalili S, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis. 2014;33:2061–6.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Breitkopf C, Dieter Hammel, Scheld HH, et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005;111:1415–142117.CrossRefPubMed Breitkopf C, Dieter Hammel, Scheld HH, et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation. 2005;111:1415–142117.CrossRefPubMed
17.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.CrossRefPubMed
18.
Zurück zum Zitat Lamas CC, Eykyn SJ. Suggested modifications to the duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis. 1997;25:713–9.CrossRefPubMed Lamas CC, Eykyn SJ. Suggested modifications to the duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis. 1997;25:713–9.CrossRefPubMed
19.
Zurück zum Zitat Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol. 2015;53:824–9.CrossRefPubMedPubMedCentral Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol. 2015;53:824–9.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Morris AJ, Drinkovic D, Pottumarthy S, et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis. 2003;36:697–704.CrossRefPubMed Morris AJ, Drinkovic D, Pottumarthy S, et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis. 2003;36:697–704.CrossRefPubMed
21.
Zurück zum Zitat Morris AJ, Drinković D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis. 2005;41:187–93.CrossRefPubMed Morris AJ, Drinković D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis. 2005;41:187–93.CrossRefPubMed
22.
Zurück zum Zitat Shrestha NK, Ledtke CS, Wang H, et al. Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients. Ann Thorac Surg. 2015;99:33–7.CrossRefPubMed Shrestha NK, Ledtke CS, Wang H, et al. Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients. Ann Thorac Surg. 2015;99:33–7.CrossRefPubMed
23.
Zurück zum Zitat Renzulli A, Carozza A, Marra C, et al. Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis? Eur J Cardiothorac Surg. 2000;17:228–33.CrossRefPubMed Renzulli A, Carozza A, Marra C, et al. Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis? Eur J Cardiothorac Surg. 2000;17:228–33.CrossRefPubMed
24.
Zurück zum Zitat Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40:527–35.CrossRefPubMed Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40:527–35.CrossRefPubMed
25.
Zurück zum Zitat Nadji G, Rusinaru D, Remadi JP, et al. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11:668–75.CrossRefPubMed Nadji G, Rusinaru D, Remadi JP, et al. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11:668–75.CrossRefPubMed
26.
Zurück zum Zitat Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141:98–106.CrossRefPubMed Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141:98–106.CrossRefPubMed
27.
Zurück zum Zitat Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44.CrossRefPubMed Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44.CrossRefPubMed
28.
Zurück zum Zitat Chu V, Cabell C, Benjamin D, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–9.CrossRefPubMed Chu V, Cabell C, Benjamin D, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–9.CrossRefPubMed
29.
Zurück zum Zitat Chu V, Park L, Athan E, et al. Association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131:131–40.CrossRefPubMed Chu V, Park L, Athan E, et al. Association between surgical indications, operative risk and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131:131–40.CrossRefPubMed
Metadaten
Titel
Histopathology of valves in infective endocarditis, diagnostic criteria and treatment considerations
verfasst von
Tatiana J. D. Brandão
Carolina A. Januario-da-Silva
Marcelo G. Correia
Monica Zappa
Jaime A. Abrantes
Angela M. R. Dantas
Wilma Golebiovski
Giovanna Ianini F. Barbosa
Clara Weksler
Cristiane C. Lamas
Publikationsdatum
22.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0953-4

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Koronare Herzkrankheit: Das waren die Top-Studien in 2024

Zum Thema Koronare Herzkrankheit gab es 2024 wichtige neue Studien. Beleuchtet wurden darin unter anderem der Stellenwert von Betablockern nach Herzinfarkt, neue Optionen für eine Lipidsenkung sowie die Therapie bei infarktbedingtem kardiogenem Schock.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.